Skip to content

Clinical Study on the Treatment of Acquired Extraocular Muscle Palsy by Direct Irritating the Attachment Points of Extraocular Muscles

Clinical Study on the Treatment of Acquired Extraocular Muscle Palsy by Direct Irritating the Attachment Points of Extraocular Muscles

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066175
Enrollment
Unknown
Registered
2022-11-25
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Extraocular Muscle Palsy

Interventions

control group :Treatment of primary disease+nutritional neurotherapy

Sponsors

Xiyuan Hospital of CACMS
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Cases meet the diagnostic criteria of Western medicine and traditional Chinese medicine for acquired extraocular palsy; 2. The subjects and their family members can understand and are willing to accept treatment and review according to the trial protocol; 3. Sign the informed consents.

Exclusion criteria

Exclusion criteria: 1. Ocular muscle palsy caused by nasopharyngeal space occupying lesions; 2. Myasthenia gravis leads to ocular paralysis; 3. Patients who underwent intraocular surgery within 3 months; 4. Those who have participated in clinical trials of any drug or medical device within 3 months before the trial, or plan to participate in other clinical trials during the trial; 5. Moderate or severe liver and kidney dysfunction, or combined with heart, liver, kidney, hematopoietic system and other serious diseases and mental patients; 6. Patients who can not cooperate examination and treatment process ; 7. Pregnant women or lactating women.

Design outcomes

Primary

MeasureTime frame
Eye muscle related examination;

Secondary

MeasureTime frame
Imaging examination;Fundoscopy examination;Intraocular pressure;Safety Specifications;Slit lamp inspection;Uncorrected vision and best corrected vision;

Countries

China

Contacts

Public ContactLiqun Chu
chuliqunok@126.com+86 10 6283 5138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026